Immuneering
IMRX
IMRX
52 hedge funds and large institutions have $119M invested in Immuneering in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
17
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$825K |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$7.89M |
| 3 |
3
Barclays
London,
United Kingdom
|
$257K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$179K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$2.75M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
| $8.58K | – | – | – |
|
|
HI
52
Harbour Investments
Madison,
Wisconsin
| $184 | – | – | – |
|
53
Invesco
Atlanta,
Georgia
| – | -$78.7K | -10,249 | Closed |
|
|
CUAMC
54
China Universal Asset Management Company
Shanghai,
China
| – | -$5.75K | -749 | Closed |
|
55
Daiwa Securities Group
Tokyo,
Japan
| – | -$1K | -76 | Closed |
|
56
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$576 | -75 | Closed |
|